Clinical Trial Update: Pharmacogenetic Dosing of Warfarin [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating pharmacogenetic dosing of warfarin has completed, assessing personalized dosing strategies. Sponsored by Academia Sinica in Ta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter
• Stroke
• Venous Thrombosis

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: Academia Sinica, Taiwan | Conditions: Stroke, Venous Thrombosis | Phase 3 | Status: COMPLETED